Post-earnings recap
Reported
Thu, May 14, 2026
EPS actual
$0.12
EPS est.
$0.07
EPS surprise
+60.00%
1-day move
+8.43%
Cellebrite DI Ltd. reported better-than-expected earnings per share, indicating stronger profitability than analysts anticipated. However, the stock did not react with any movement, remaining unchanged. The lack of revenue data and guidance may leave investors uncertain about future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.12 | $0.09 | +60.00% |
| Revenue | — | $127M | — |
No transcript is on record, and the analysis is based on numerical results only.
Cellebrite DI Ltd. (CLBT) operates in the Information Technology sector, specifically in application software. The company specializes in digital intelligence solutions that help law enforcement and enterprises manage and analyze data from mobile devices, which is increasingly important in today's digital age.
Last quarter
In Q4-2025, Cellebrite reported an EPS of $0.14, exceeding estimates by 33.33%. However, the stock fell 4.55% the following day, indicating market skepticism despite the earnings beat.
Management promises and guidance
EPS beat streak
8Q
EPS beat rate
100%
Avg EPS surprise
+49.68%
Avg 1-day reaction
-4.88%
Analysts expect Cellebrite to report solid earnings, with a consensus EPS of $0.09 and revenue of $127M. The company has consistently beaten EPS estimates in the past, which could set a positive tone.
Bull case
If Cellebrite continues its streak of beating EPS estimates, it could signal strong operational performance and investor confidence, potentially driving the stock higher.
Bear case
Conversely, if the company fails to meet expectations or provides cautious guidance, it could lead to a decline in stock price, particularly given the recent history of post-earnings sell-offs.
Key metrics to watch
EPS
$0.09Earnings per share is a key indicator of profitability and investor returns.
Revenue
$127MRevenue growth is crucial for assessing the company's performance and market demand.
The print will turn on these.
Q1
Will EPS exceed the consensus estimate of $0.09?
A beat on EPS would reinforce the company's strong performance trend and could positively influence investor sentiment.
Q2
What guidance will management provide for future revenue growth?
Future revenue guidance is critical for assessing the company's growth trajectory and could impact stock performance significantly.
—
Est. EPS
$0.93
Est. Rev
$339M
Impl. Move
±18.4%
Why consensus could be wrong
The Street may be underestimating the potential for Cellebrite to exceed revenue expectations due to increased demand for digital intelligence solutions.
Supporting evidence
Cellebrite has consistently beaten EPS estimates, indicating strong operational execution.
The options market is pricing in a larger move than historical averages, suggesting heightened expectations.
Recent trends in law enforcement and enterprise data management indicate growing market demand.
Key risk
If revenue growth significantly exceeds $128M, it could challenge the current bearish sentiment.
Pre-commit to what would confirm each case.
The market is debating whether the company can maintain its growth momentum amid competitive pressures and economic conditions.
Bull confirmed if
An EPS of $0.10 or higher with revenue exceeding $128M would confirm the bullish case.
Bear confirmed if
An EPS below $0.08 or revenue below $126M would support the bearish outlook.
What the market is pricing for the move.
Implied Move
±11.58%
Historical Avg
±9.7%
The options market is pricing in a significant move, suggesting that investors are anticipating volatility around the earnings report.
Options are pricing ±11.6% while CLBT has averaged ±9.7% over the last 8 prints — setup is pricing rich.
ATM IV
1.6%
30d HV
61.4%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Cellebrite beats expectations, history suggests the stock could rise by an average of 1.5%, confirming strong operational performance.
In line / cautious
If results are in line but management's commentary is cautious, the stock may experience moderate volatility as investors reassess growth prospects.
Miss
Should the company miss expectations, the average reaction has been a decline of around 11.48%, reflecting investor disappointment.
The lines on the call that would change the story.